. home.aspx

home.aspx
   

Aerpio initiates clinical trial of AKB-9778 for treatment of PAOG

June 12, 2019 / PANKAJ SINGH

A US-based pharmaceutical company, Aerpio Pharmaceuticals, Inc., recently announced the initiation of Phase 1b clinical trial of AKB-9778 to develop treatment of PAOG (primary open angle glaucoma), report sources.

Popular Topics